Federated Hermes, Inc. Celcuity Inc. Transaction History

Federated Hermes, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$7.93 - $13.33 $2.48 Million - $4.17 Million	-312,908 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$14.25 - $30.93 $524,642 - $1.14 Million	36,817 Added 13.34%	312,908 $7.51 Million
Q1 2021 May 13, 2021	BUY	$10.43 - $17.8 $2.88 Million - $4.91 Million	276,091 New	276,091 $3.96 Million

107

30.3M

30.8K

152K

Ticker CELC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,941,300
Market Cap $187M
Description
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.